Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01780701 · ClinicalTrials.gov registry record
Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate Cancer
A clinical trial, sponsored by OHSU Knight Cancer Institute.
- Completed
- Registry status
- 66
- Enrollment target
NCT01780701 is a clinical trial that has completed, run by OHSU Knight Cancer Institute. The registered enrollment target is 66 participants.
The verdict
NCT01780701 has completed, sponsored by OHSU Knight Cancer Institute.
- COMPLETED
- Registry status
- 66 participants
- Enrollment target
Study Summary
A prostate cancer diagnosis starts a list of events that often leads to fast-moving treatment, thought by many to result in vast over-treatment of this disease. So, discovery of different diagnostic methods that allow clinicians to identify slow-growing from potentially fast-growing disease prior to or at the time of prostate biopsy could result in early and suitable treatment for men at greatest risk, while greatly decreasing the number of biopsies, surgical procedures, hormonal and chemotherapeutic treatments, cost, and patient worry, for those with more slow-growing disease.
Interventions
- PROCEDURE Magnetic Resonance Spectroscopy Imaging with rectal probe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2013-01 |
| Est. Completion | 2017-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01780701
The ClinicalTrials.gov registry entry for NCT01780701 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OHSU Knight Cancer Institute, which has 211 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Magnetic Resonance Spectroscopy Imaging with rectal probe is the first listed.
NCT01780701 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01780701 about?
NCT01780701 is a clinical study titled "Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate Cancer". A prostate cancer diagnosis starts a list of events that often leads to fast-moving treatment, thought by many to result in vast over-treatment of this disease. So, discovery of different diagnostic methods that allow clinicians to identify slow-growing from potentially fast-growing disease prior to...
What is the current status of trial NCT01780701?
This trial is currently completed. The enrollment target is 66 participants. The study started on 2013-01. Estimated completion is 2017-03.
What interventions are being tested in trial NCT01780701?
The interventions under investigation include: Magnetic Resonance Spectroscopy Imaging with rectal probe (PROCEDURE).
Who is sponsoring clinical trial NCT01780701?
This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.